{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:30:24Z","timestamp":1792787424906,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Lundbeck A\/S"},{"name":"Innovation Fund Denmark","award":["4135-00084B"],"award-info":[{"award-number":["4135-00084B"]}],"id":[{"id":"https:\/\/ror.org\/00daj4111","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2015-68346-P"],"award-info":[{"award-number":["SAF2015-68346-P"]}],"id":[{"id":"https:\/\/ror.org\/01txxn211","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI12\/00156"],"award-info":[{"award-number":["PI12\/00156"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI16\/00287)"],"award-info":[{"award-number":["PI16\/00287)"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (Spanish Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Generalitat de Catalunya Grup de Recerca Consolidat","award":["2017SGR717"],"award-info":[{"award-number":["2017SGR717"]}],"id":[{"id":"https:\/\/ror.org\/01bg62x04","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.neuropharm.2018.04.022","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T12:33:16Z","timestamp":1524573196000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks"],"prefix":"10.1016","volume":"137","author":[{"given":"Maria","family":"Amat-Foraster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-5052","authenticated-orcid":false,"given":"Anders A.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Plath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-0394","authenticated-orcid":false,"given":"Kjartan F.","family":"Herrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3893-9000","authenticated-orcid":false,"given":"Pau","family":"Celada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.04.022_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","article-title":"The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate","volume":"79","author":"Anis","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0361-9230(96)00107-4","article-title":"GABAergic neurons in mammalian thalamus: a marker of thalamic complexity?","volume":"42","author":"Arcelli","year":"1997","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib4","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","article-title":"Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders","volume":"32","author":"Beneyto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fphar.2013.00161","article-title":"Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants","volume":"4","author":"Browne","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib6","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1126\/science.1099745","article-title":"Neuronal oscillations in cortical networks","volume":"304","author":"Buzsaki","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nature08002","article-title":"Driving fast-spiking cells induces gamma rhythm and controls sensory responses","volume":"459","author":"Cardin","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/mp.2011.31","article-title":"A\u00a0critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior","volume":"17","author":"Carlen","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/schbul\/sbs076","article-title":"NMDA receptor and schizophrenia: a brief history","volume":"38","author":"Coyle","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib10","doi-asserted-by":"crossref","first-page":"9761","DOI":"10.1523\/JNEUROSCI.23-30-09761.2003","article-title":"Gamma oscillations induced by kainate receptor activation in the entorhinal cortex in\u00a0vitro","volume":"23","author":"Cunningham","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(88)90063-8","article-title":"Ketamine blocks an NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner","volume":"92","author":"Davies","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib12","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/npp.2014.26","article-title":"Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks","volume":"39","author":"Dawson","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/schbul\/sbr144","article-title":"Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems","volume":"39","author":"Dawson","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuroimage.2012.09.037","article-title":"Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers","volume":"64","author":"De Simoni","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib15","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3109\/00498254.2012.685777","article-title":"Stereoselective and regiospecific hydroxylation of ketamine and norketamine","volume":"42","author":"Desta","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.euroneuro.2016.03.006","article-title":"Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate","volume":"26","author":"Downey","year":"2016","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/jpet.112.201665","article-title":"Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents","volume":"345","author":"Doyle","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1113\/jphysiol.2006.124958","article-title":"Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block","volume":"581","author":"Dravid","year":"2007","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","article-title":"Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression","volume":"33","author":"Feyissa","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib21","doi-asserted-by":"crossref","first-page":"8106","DOI":"10.1073\/pnas.1414728112","article-title":"Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions","volume":"112","author":"Fuchikami","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib22","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/npp.2015.233","article-title":"The antidepressant effects of an mGlu2\/3 receptor antagonist and ketamine require AMPA receptor stimulation in the mPFC and subsequent activation of the 5-HT neurons in the DRN","volume":"41","author":"Fukumoto","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cne.20738","article-title":"Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers","volume":"492","author":"Gabbott","year":"2005","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib24","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1038\/tp.2017.7","article-title":"Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats","volume":"7","author":"Gasull-Camos","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib25","first-page":"1545","volume":"388","author":"GBD","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.neuropharm.2009.01.012","article-title":"Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1\/GluN2A) receptors","volume":"56","author":"Gilling","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib28","doi-asserted-by":"crossref","first-page":"e6755","DOI":"10.1371\/journal.pone.0006755","article-title":"NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness","volume":"4","author":"Hakami","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib29","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/npp.2013.19","article-title":"GluN2B antagonism affects interneurons and leads to immediate and persistent changes in synaptic plasticity, oscillations, and behavior","volume":"38","author":"Hanson","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal glutamate\/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy","volume":"64","author":"Hasler","year":"2007","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2014.03.025","article-title":"Metabotropic glutamate receptors regulate cortical gamma hyperactivities elicited by ketamine in rats","volume":"567","author":"Hiyoshi","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib32","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib33","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1073\/pnas.0308455101","article-title":"NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex","volume":"101","author":"Jackson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S1461145711000848","article-title":"Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power","volume":"15","author":"Jones","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.mcn.2006.12.001","article-title":"Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-beta-galactosidase knock-in mice","volume":"34","author":"Karavanova","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib36","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","article-title":"Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine","volume":"104","author":"Kargieman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib37","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib38","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.1523\/JNEUROSCI.1203-16.2016","article-title":"The role of GluN2C-containing NMDA receptors in Ketamine's psychotogenic action and in schizophrenia models","volume":"36","author":"Khlestova","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00429-011-0351-8","article-title":"Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia","volume":"217","author":"Kittelberger","year":"2012","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2014.05.065","article-title":"Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats","volume":"271","author":"Koike","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib41","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1523\/JNEUROSCI.3703-08.2009","article-title":"Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine","volume":"29","author":"Kotermanski","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-003-1582-z","article-title":"NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development","volume":"169","author":"Krystal","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0301-0082(97)00070-1","article-title":"An ultrastructural study of the neural circuit between the prefrontal cortex and the mediodorsal nucleus of the thalamus","volume":"54","author":"Kuroda","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib44","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1523\/JNEUROSCI.1168-05.2005","article-title":"A\u00a0subpopulation of neurons in the medial prefrontal cortex encodes emotional learning with burst and frequency codes through a dopamine D4 receptor-dependent basolateral amygdala input","volume":"25","author":"Laviolette","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib45","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/hbm.23085","article-title":"The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: a randomized controlled study","volume":"37","author":"Li","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib46","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib47","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib48","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.neuroimage.2006.05.022","article-title":"Using the BOLD MR signal to differentiate the stereoisomers of ketamine in the rat","volume":"32","author":"Littlewood","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.euroneuro.2015.11.015","article-title":"Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: effects of antipsychotic drugs and receptor ligands","volume":"26","author":"Llado-Pelfort","year":"2016","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib50","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1113\/jphysiol.1991.sp018396","article-title":"Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones","volume":"432","author":"MacDonald","year":"1991","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib52","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00213-015-4175-8","article-title":"Ketamine-induced brain activation in awake female nonhuman primates: a translational functional imaging model","volume":"233","author":"Maltbie","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib53","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib54","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.conb.2014.12.004","article-title":"Antidepressant actions of ketamine: from molecular mechanisms to clinical practice","volume":"30","author":"Monteggia","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib56","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0028-3908(85)90137-6","article-title":"Quantitative electrocortical changes in the rat induced by phencyclidine and other stimulants","volume":"24","author":"Neal","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib58","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0306-4522(83)90060-X","article-title":"Neural elements containing glutamic acid decarboxylase (GAD) in the dorsal lateral geniculate nucleus of the rat; immunohistochemical studies by light and electron microscopy","volume":"8","author":"Ohara","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib60","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib61","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/2045125312445469","article-title":"The drugs don't work? antidepressants and the current and future pharmacological management of depression","volume":"2","author":"Penn","year":"2012","journal-title":"Therapeut. Adv. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib62","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.neuropharm.2011.04.006","article-title":"Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia","volume":"62","author":"Phillips","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2004.04.008","article-title":"The thalamic reticular nucleus: structure, function and concept","volume":"46","author":"Pinault","year":"2004","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib64","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.biopsych.2007.10.006","article-title":"N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex","volume":"63","author":"Pinault","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib65","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1460-9568.1994.tb00621.x","article-title":"Anatomical and electrophysiological evidence for an excitatory amino acid pathway from the thalamic mediodorsal nucleus to the prefrontal cortex in the rat","volume":"6","author":"Pirot","year":"1994","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib66","doi-asserted-by":"crossref","first-page":"634","DOI":"10.12688\/f1000research.8236.1","article-title":"In search of the mechanisms of ketamine's antidepressant effects: how robust is the evidence behind the mTor activation hypothesis","volume":"5","author":"Popp","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/neuro.06.013.2009","article-title":"A\u00a0defined network of fast-spiking interneurons in orbitofrontal cortex: responses to behavioral contingencies and ketamine administration","volume":"3","author":"Quirk","year":"2009","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib68","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib69","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.4088\/JCP.09ac05757blu","article-title":"Do glutamatergic agents represent a new class of antidepressant drugs? Part 2","volume":"70","author":"Sanacora","year":"2009","journal-title":"J.\u00a0Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib70","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/npp.2016.193","article-title":"Balancing the promise and risks of ketamine treatment for mood disorders","volume":"42","author":"Sanacora","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib71","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/mp.2013.130","article-title":"Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects","volume":"19","author":"Sanacora","year":"2014","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib73","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2010.10.030","article-title":"Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine","volume":"69","author":"Santana","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib74","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuropharm.2014.07.008","article-title":"Enhancing ketamine translational pharmacology via receptor occupancy normalization","volume":"86","author":"Shaffer","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib75","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A\u00a0double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-4328(01)00223-6","article-title":"Histamine reduces firing and bursting of anterior and intralaminar thalamic neurons and activates striatal cells in anesthetized rats","volume":"124","author":"Sittig","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-979537","article-title":"Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression","volume":"29","author":"Skolnick","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib78","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2009.09.002","article-title":"Glutamate-based antidepressants: 20 years on","volume":"30","author":"Skolnick","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib79","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0006-3223(00)00957-4","article-title":"Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline","volume":"48","author":"Stahl","year":"2000","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib80","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1073\/pnas.071051998","article-title":"The GABAergic reticular nucleus: a preferential target of corticothalamic projections","volume":"98","author":"Steriade","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib81","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.8235588","article-title":"Thalamocortical oscillations in the sleeping and aroused brain","volume":"262","author":"Steriade","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib82","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature22084","article-title":"Effects of a ketamine metabolite on synaptic NMDAR function","volume":"546","author":"Suzuki","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib83","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2174\/156802611797470376","article-title":"Thalamocortical oscillations: local control of EEG slow waves","volume":"11","author":"Timofeev","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib84","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib85","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.biopsych.2014.05.019","article-title":"Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain","volume":"76","author":"Troyano-Rodriguez","year":"2014","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib86","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1523\/JNEUROSCI.4883-11.2012","article-title":"Differentiated participation of thalamocortical subnetworks in slow\/spindle waves and desynchronization","volume":"32","author":"Ushimaru","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib87","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib88","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1471-4159.1997.68020469.x","article-title":"NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins","volume":"68","author":"Wenzel","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib89","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0167-8760(00)00173-2","article-title":"Inhibition-based rhythms: experimental and mathematical observations on network dynamics","volume":"38","author":"Whittington","year":"2000","journal-title":"Int. J. Psychophysiol."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib90","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1523\/JNEUROSCI.6377-11.2012","article-title":"Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs","volume":"32","author":"Wood","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib91","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00001756-199306000-00021","article-title":"Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists","volume":"4","author":"Yamakura","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib92","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.04.022_bib93","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A\u00a0randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.04.022_bib94","first-page":"20","article-title":"Inhibition of NMDARs in the nucleus reticularis of the thalamus produces delta frequency bursting","volume":"3","author":"Zhang","year":"2009","journal-title":"Front. Neural Circ."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818301771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818301771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T20:46:51Z","timestamp":1569098811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818301771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":94,"alternative-id":["S0028390818301771"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.04.022","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}